GlassScriptPhysician profile
Nicholas E Villalobos
NPI 1841677069
$25,808.52
in general payments reported to CMS, 2019-2025
15 companies · $8,112 in 2025
The $8,112 reported for 2025 was more than what 94% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $258 · 2023: $2,985 · 2024: $14K · 2025: $8,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Long Term Medical Supply Or Device Loan: $3,500 · Food and Beverage: $2,309 · Honoraria: $2,000 · Travel and Lodging: $1,888 · Education: $51.40 · Gift: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,751.50 |
| Long Term Medical Supply Or Device Loan | $3,500.00 |
| Food and Beverage | $2,309.47 |
| Honoraria | $2,000.00 |
| Travel and Lodging | $1,888.34 |
| Education | $51.40 |
| Gift | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Sonosite, INC. | $8,459.78 | 2023-2024 | Sonosite Px Ultrasound System |
| Maquet Cardiopulmonary Gmbh | $6,688.70 | 2025 | Hls Set |
| Mylan Specialty L.P. | $4,142.65 | 2022-2024 | |
| Exo Imaging, INC. | $3,550.00 | 2024 | Exo Iris |
| Insmed, INC. | $907.04 | 2023-2025 | Arikayce |
| Getinge USA Sales, LLC | $521.84 | 2025 | Vasoview Hemopro 2 |
| Actelion Pharmaceuticals US, INC. | $412.33 | 2024-2025 | Uptravi, Opsynvi, Opsumit |
| Ultrasight INC | $350.00 | 2024 | Ultrasight Ai Guidance |
| Ge Healthcare | $169.33 | 2024-2025 | |
| Abiomed | $143.89 | 2024 | Impella |
| Abbvie INC. | $124.99 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2023 | Ofev |
| Merck Sharp & Dohme LLC | $94.99 | 2022-2025 | Winrevair |
| Fresenius USA Marketing, INC. | $83.22 | 2025 | Novalung System |
| Abbott Laboratories | $34.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Villalobos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.